Vivus Inc Drug Patent Portfolio
Vivus Inc owns 1 orange book drug protected by 5 US patents Given below is the list of Vivus Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8221747 | Stable pancreatic enzyme compositions | 20 Feb, 2028 | Active |
| US8562978 | Stable digestive enzyme compositions | 20 Feb, 2028 | Active |
| US8562979 | Stable digestive enzyme compositions | 20 Feb, 2028 | Active |
| US8562980 | Stable digestive enzyme compositions | 20 Feb, 2028 | Active |
| US8562981 | Stable digestive enzyme compositions | 20 Feb, 2028 | Active |
Latest Legal Activities on Vivus Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Vivus Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 03 Jan, 2024 | US8221747 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 07 Apr, 2021 | US8562978 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 07 Apr, 2021 | US8562981 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 07 Apr, 2021 | US8562979 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 07 Apr, 2021 | US8562980 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 17 Jan, 2020 | US8221747 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Sep, 2014 | US8221747 |
|
Email Notification
Critical
| 29 Sep, 2014 | US8562978 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Sep, 2014 | US8562981 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Sep, 2014 | US8562979 |
|
Email Notification
Critical
| 29 Sep, 2014 | US8562980 |
|
Email Notification
Critical
| 29 Sep, 2014 | US8221747 |
|
Email Notification
Critical
| 29 Sep, 2014 | US8562979 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Sep, 2014 | US8562978 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Sep, 2014 | US8562980 |
Vivus Inc's Family Patents
Vivus Inc Drug List
Given below is the complete list of Vivus Inc's drugs and the patents protecting them.
1. Pancreaze
Pancreaze is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8221747 | Stable pancreatic enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
| US8562978 | Stable digestive enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
| US8562979 | Stable digestive enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
| US8562980 | Stable digestive enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
| US8562981 | Stable digestive enzyme compositions |
20 Feb, 2028
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Pancreaze's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List